Free Trial

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Sees Large Decrease in Short Interest

Curaleaf logo with Medical background

Key Points

  • Curaleaf Holdings, Inc. experienced a substantial 19.5% decrease in short interest during August, dropping from 5,126,800 shares to 4,126,300 shares.
  • The company's stock has a current market cap of $1.97 billion and reported earnings of ($0.06) per share, beating analysts' estimates.
  • Cormark upgraded Curaleaf's stock rating from "hold" to a "moderate buy" on August 8th, with an overall average rating of "Strong Buy" from analysts.
  • Interested in Curaleaf? Here are five stocks we like better.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) was the target of a significant decline in short interest in August. As of August 15th, there was short interest totaling 4,126,300 shares, adeclineof19.5% from the July 31st total of 5,126,800 shares. Based on an average trading volume of 5,118,500 shares, the short-interest ratio is presently 0.8 days. Based on an average trading volume of 5,118,500 shares, the short-interest ratio is presently 0.8 days.

Curaleaf Stock Performance

Shares of CURLF opened at $2.94 on Tuesday. The company has a current ratio of 1.47, a quick ratio of 0.70 and a debt-to-equity ratio of 1.00. The stock has a market cap of $1.97 billion, a P/E ratio of -9.19 and a beta of 0.75. The company has a 50-day moving average of $1.95 and a two-hundred day moving average of $1.27. Curaleaf has a 12-month low of $0.68 and a 12-month high of $3.65.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, research analysts predict that Curaleaf will post -0.25 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Cormark upgraded shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, the stock has an average rating of "Strong Buy".

Check Out Our Latest Research Report on Curaleaf

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.